世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035741

NASH治療および治療薬市場レポート 2023-2033

Visiongain

NASH Treatment & Therapeutics Market Report 2023-2033

発刊日 2023/07/27

言語英語

体裁PDF/224ページ

ライセンス/価格224ページ

0000035741

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

製品の種類別予測(ビタミンEおよびPioglitazone、Ocaliva,、Elafibranor、Selonsertib、Cenicriviroc,、、その他)、用途別(治療、診断)、販売チャネル別(院内薬局、オンラインプロバイダー、小売薬局、その他)、地域および主要国内市場別の予測分析に加え、主要企業の分析とCOVID-19の影響と回復パターンの分析

非アルコール性脂肪性肝炎(NASH)の有病率の増加が市場の成長を牽引
NASH治療および治療薬市場を推進する主な要因には、特に発展途上国における国民のNASH有病率の増加があります。さらに、研究ではNASHの発生率と有病率が大幅に上昇しており、重大な公衆衛生上の問題となっていることが示されており、市場の成長をさらに促進すると予想されています。一方、米国や欧州などの先進国では、NASH が C 型肝炎を上回り、慢性肝疾患の主な原因として浮上しています。肥満、2 型糖尿病、メタボリックシンドロームの有病率はすべて NASH の危険因子です。 、着実に増加しており、NASH症例の増加に貢献しています。さらに、急速な都市化、座りがちなライフスタイル、高カロリーの加工食品の摂取などの食事パターンの変化によって、さらに、発症をさらに加速させ、市場の成長を促しています。
さらに、NASH は先進国に限定されず、発展途上国でも懸念が高まっています。これらの国では急速な経済成長、都市化、西洋化されたライフスタイルの傾向が進むにつれて、NASH の有病率も同時に増加しています。

レポート詳細

目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to NASH Treatment & Therapeutics Market (Pipeline Analysis)
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of NASH
3.2.1.2 Growing Awareness and Diagnosis
3.2.1.3 Increasing Healthcare Expenditure
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Approved Therapies
3.2.2.2 Complex Disease Pathogenesis
3.2.2.3 Clinical Trial Failures
3.2.3 Market Opportunities
3.2.3.1 Technological Advancements
3.2.3.2 Collaborations and Partnerships
3.2.3.3 Diagnostic Tools and Biomarkers
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.6 Drug Pipeline Analysis

4 NASH Treatment & Therapeutics Market Analysis by Product Type
4.1 Key Findings
4.2 NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Product Type
4.3 Vitamin E and Pioglitazone
4.4 Ocaliva
4.5 Elafibranor
4.6 Selonsertib
4.7 Cenicriviroc
4.8 Others

5 NASH Treatment & Therapeutics Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
5.4 Treatment
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Diagnosis
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)

6 NASH Treatment & Therapeutics Market Analysis by Sales Channel
6.1 Key Findings
6.2 Sales Channel Segment: Market Attractiveness Index
6.3 NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
6.4 Hospital Pharmacy
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Online Provider
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Retail Pharmacy
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Others
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 NASH Treatment & Therapeutics Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America NASH Treatment & Therapeutics Market Analysis
8.1 Key Findings
8.2 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
8.3 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Country
8.5 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
8.6 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
8.7 U.S. NASH Treatment & Therapeutics Market Analysis
8.8 Canada NASH Treatment & Therapeutics Market Analysis

9 Europe NASH Treatment & Therapeutics Market Analysis
9.1 Key Findings
9.2 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
9.3 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Country
9.5 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
9.6 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
9.7 Germany NASH Treatment & Therapeutics Market Analysis
9.8 France NASH Treatment & Therapeutics Market Analysis
9.9 UK NASH Treatment & Therapeutics Market Analysis
9.10 Italy NASH Treatment & Therapeutics Market Analysis
9.11 Spain NASH Treatment & Therapeutics Market Analysis
9.12 Russia NASH Treatment & Therapeutics Market Analysis
9.13 Rest of Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Analysis

10 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) analysis
10.1 Key Findings
10.2 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
10.3 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Country
10.5 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
10.6 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
10.7 Japan NASH Treatment & Therapeutics Market Analysis
10.8 China NASH Treatment & Therapeutics Market Analysis
10.9 India NASH Treatment & Therapeutics Market Analysis
10.10 Australia NASH Treatment & Therapeutics Market (Pipeline Analysis) Analysis
10.11 South Korea NASH Treatment & Therapeutics Market Analysis
10.12 Singapore NASH Treatment & Therapeutics Market Analysis
10.13 Rest of Asia Pacific NASH Treatment & Therapeutics Market Analysis

11 Latin America NASH Treatment & Therapeutics Market Analysis
11.1 Key Findings
11.2 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
11.3 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Country
11.5 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
11.6 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
11.7 Brazil NASH Treatment & Therapeutics Market Analysis
11.8 Mexico NASH Treatment & Therapeutics Market Analysis
11.9 Argentina NASH Treatment & Therapeutics Market Analysis
11.10 Colombia NASH Treatment & Therapeutics Market Analysis
11.11 Rest of Latin America NASH Treatment & Therapeutics Market Analysis

12 Middle East and Africa NASH Treatment & Therapeutics Market Analysis
12.1 Key Findings
12.2 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
12.3 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Country
12.5 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Application
12.6 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Size Estimation and Forecast by Sales Channel
12.7 GCC NASH Treatment & Therapeutics Market Analysis
12.8 South Africa NASH Treatment & Therapeutics Market Analysis
12.9 Rest of Middle East and Africa NASH Treatment & Therapeutics Market Analysis

13 Company Profiles
13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 Intercept Pharmaceuticals, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 R&D, 2017-2022
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Gilead Sciences Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 .Net Revenue, 2017-2022
13.4.3.2 R&D, 2017-2022
13.4.3.3 Regional Market Shares, 2022
13.4.4 Product Benchmarking
13.5 Genfit Pharma S.A.S
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2022
13.5.3.2 R&D, 2017-2022
13.5.4 Product Benchmarking
13.6 BioPredictive S.A.S
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 Galmed Pharmaceuticals Ltd.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Strategic Outlook
13.8 Cadila Pharmaceuticals Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Prometheus Laboratories Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 AbbVie Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2022
13.10.3.2 R&D, 2017-2022
13.10.3.3 Regional Market Shares, 2022
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 Enanta Pharmaceuticals Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2022
13.11.4 Product Benchmarking
13.12 Genentech, Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
?

List of Tables
Table 1 NASH Treatment & Therapeutics Market (Pipeline Analysis) Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Product Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Online Provider Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 U.S. NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Canada NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Germany NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 France NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 UK NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Italy NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Spain NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Russia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Rest of Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Japan NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 China NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 India NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Australia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 South Korea NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Singapore NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Rest of Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Brazil NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Mexico NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Argentina NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Colombia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 GCC NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 South Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Rest of Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Strategic Outlook
Table 56 Intercept Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 57 Intercept Pharmaceuticals, Inc.: Product Benchmarking
Table 58 Intercept Pharmaceuticals, Inc.: Strategic Outlook
Table 59 Gilead Sciences Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Gilead Sciences Inc.: Product Benchmarking
Table 61 Genfit Pharma S.A.S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 62 Genfit Pharma S.A.S: Product Benchmarking
Table 63 BioPredictive S.A.S: Key Details, (HQ, Company Type, Website, Business Segment)
Table 64 BioPredictive S.A.S: Product Benchmarking
Table 65 Galmed Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Founded, Company Type, Website, Business Segment)
Table 66 Galmed Pharmaceuticals Ltd.: Product Benchmarking
Table 67 Galmed Pharmaceuticals Ltd.: Strategic Outlook
Table 68 Cadila Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Cadila Pharmaceuticals Ltd.: Product Benchmarking
Table 70 Prometheus Laboratories Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Prometheus Laboratories Inc.: Product Benchmarking
Table 72 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 AbbVie Inc.: Product Benchmarking
Table 74 AbbVie Inc.: Strategic Outlook
Table 75 Enanta Pharmaceuticals Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Enanta Pharmaceuticals Inc.: Product Benchmarking
Table 77 Genentech, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Genentech, Inc.: Product Benchmarking
?

List of Figures
Figure 1 NASH Treatment & Therapeutics Market (Pipeline Analysis) Segmentation
Figure 2 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Application: Market Attractiveness Index
Figure 3 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Sales Channel: Market Attractiveness Index
Figure 4 NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index by Region
Figure 5 NASH Treatment & Therapeutics Market (Pipeline Analysis): Market Dynamics
Figure 6 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 7 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 8 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 9 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 10 NASH Treatment & Therapeutics Market (Pipeline Analysis): Porter’s Five Forces Analysis
Figure 11 NASH Treatment & Therapeutics Market (Pipeline Analysis): PEST Analysis
Figure 12 NASH Treatment & Therapeutics Market (Pipeline Analysis): Drug Pipeline Analysis
Figure 13 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Product Type, 2023-2033 (US$ Million, AGR %)
Figure 14 NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Product Type, 2023, 2028, 2033 (%)
Figure 15 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Application: Market Attractiveness Index
Figure 16 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 17 NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 18 Treatment Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Treatment Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Diagnosis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 21 Diagnosis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Sales Channel: Market Attractiveness Index
Figure 23 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 24 NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023, 2028, 2033 (%)
Figure 25 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Hospital Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Online Provider Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Online Provider Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Retail Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 32 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 34 NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Region 2023, 2028, 2033 (%)
Figure 35 NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
Figure 37 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023, 2028 & 2033 (US$ Million)
Figure 38 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 39 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Country, 2023 & 2033 (%)
Figure 40 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 41 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023 & 2033 (%)
Figure 42 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 43 North America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023 & 2033 (%)
Figure 44 U.S. NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 45 Canada NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 46 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
Figure 47 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023, 2028 & 2033 (US$ Million)
Figure 48 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 49 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Country, 2023 & 2033 (%)
Figure 50 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 51 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023 & 2033 (%)
Figure 52 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 53 Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023 & 2033 (%)
Figure 54 Germany NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 France NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 56 UK NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 57 Italy NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 58 Spain NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 59 Russia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 60 Rest of Europe NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 61 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
Figure 62 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023, 2028 & 2033 (US$ Million)
Figure 63 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 64 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Country, 2023 & 2033 (%)
Figure 65 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 66 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023 & 2033 (%)
Figure 67 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 68 Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023 & 2033 (%)
Figure 69 Japan NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 China NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 India NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Australia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 South Korea NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Singapore NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Rest of Asia Pacific NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 76 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
Figure 77 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023, 2028 & 2033 (US$ Million)
Figure 78 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 79 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Country, 2023 & 2033 (%)
Figure 80 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 81 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023 & 2033 (%)
Figure 82 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 83 Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023 & 2033 (%)
Figure 84 Brazil NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 Mexico NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 Argentina NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Colombia NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Rest of Latin America NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Attractiveness Index
Figure 90 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) by Region, 2023, 2028 & 2033 (US$ Million)
Figure 91 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 92 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Country, 2023 & 2033 (%)
Figure 93 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 94 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Application, 2023 & 2033 (%)
Figure 95 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast by Sales Channel, 2023-2033 (US$ Million, AGR %)
Figure 96 Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Share Forecast by Sales Channel, 2023 & 2033 (%)
Figure 97 GCC NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 South Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Rest of Middle East and Africa NASH Treatment & Therapeutics Market (Pipeline Analysis) Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 NASH Treatment & Therapeutics Market (Pipeline Analysis): Company Share/Ranking, 2022
Figure 101 Intercept Pharmaceuticals, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 102 Intercept Pharmaceuticals, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 103 Gilead Sciences Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 104 Gilead Sciences Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 105 Gilead Sciences Inc.: Regional Market Shares, 2022
Figure 106 Genfit Pharma S.A.S: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 107 Genfit Pharma S.A.S: R&D, 2017-2022 (US$ Million, AGR%)
Figure 108 AbbVie Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 109 AbbVie Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 110 AbbVie Inc.: Regional Market Shares, 2022
Figure 111 Enanta Pharmaceuticals Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)

この商品のレポートナンバー

0000035741

TOP